Answers are grounded in this paper and cite their sources.
Background: Missed miscarriages (MMs) occur when an embryo without a cardiac pulse or gestational sac is not expelled from the uterus. Fibroblast growth factor-21 (FGF-21), a member of the fibroblast growth factor family, plays an important regulatory role in metabolism, primarily in glucose and lipid metabolism. Objective: The aim of this study is to investigate whether serum levels of FGF-21 are associated with MM in 8–14 weeks of gestation. Materials and Methods: This case–control study consisted of 88 pregnant women; they were divided into two groups: healthy pregnant (HP), composed of 40 women with a normal viable pregnancy at 8–14 weeks of gestation with mean age (29.07 ± 6.96 years); and study group that included 40 women with MM diagnosed by ultrasound at the same gestational age (GA) with mean age (28.27 ± 7.74 years). Demographic criteria and maternal serum FGF-21 levels were recorded for comparison. ELISA technique was used to measure FGF-21 in circulation. Results: This study revealed a statistically significant increase in serum levels of FGF-21 in MMs (142.47 ± 48.036 pg/ml) compared to normal pregnant women (87.9 ± 30.86). The cutoff point was ≥149.97, with high sensitivity (73.2%) and specificity (97.9%). There was no significant correlation between FGF-21 levels and age, GA, body mass index, or gravidity. Conclusion: The MM group’s serum concentrations of FGF-21 were markedly elevated within a time frame of 8–14 weeks compared to the HP group, suggesting its involvement in the development of MM. Based on the findings, FGF21 demonstrates a remarkable capacity for diagnosing MM.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: